China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research report released on Thursday. The brokerage issued a hold rating on the stock.

China Pharma Stock Down 4.0 %

Shares of CPHI stock opened at $0.29 on Thursday. China Pharma has a 12-month low of $0.27 and a 12-month high of $2.18. The firm has a 50-day moving average price of $0.33 and a 200 day moving average price of $0.43. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.89 and a quick ratio of 0.25.

China Pharma (NYSE:CPHIGet Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%. The firm had revenue of $1.37 million for the quarter.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

See Also

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.